Sionna Therapeutics, Inc.
SION
$35.60
-$0.46-1.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -18.07M | -16.48M | -15.85M | -8.55M | |
| Total Depreciation and Amortization | 147.00K | 159.00K | 167.00K | 166.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 2.16M | 1.89M | 764.00K | 358.00K | |
| Change in Net Operating Assets | -2.40M | -1.85M | 3.14M | -2.12M | |
| Cash from Operations | -18.15M | -16.29M | -11.78M | -10.15M | |
| Capital Expenditure | 0.00 | -86.00K | -27.00K | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -23.25M | -141.11M | 15.26M | -28.62M | |
| Cash from Investing | -23.25M | -141.19M | 15.23M | -28.62M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 202.39M | 25.00K | 38.00K | |
| Repurchase of Common Stock | -312.00K | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -1.43M | -- | |
| Cash from Financing | -312.00K | 202.39M | -1.41M | 38.00K | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -41.71M | 44.91M | 2.04M | -38.73M | |